PREVYMIS 240 mg/1 (Letermovir TABLET, FILM COATED) 240 mg/1

Prevymis 240 mg is an antiviral medication used to prevent cytomegalovirus (CMV) infection in adults. This film-coated tablet is designed for oral administration and is commonly prescribed for post-transplant patients.

Strength

240 mg/1

Pack Size

14 BLISTER PACK in 1 CARTON (0006-3075-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0006-3075-03)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Prevymis 240 mg is primarily used to prevent CMV infection in adults who have received a stem cell transplant. This medication is often prescribed to reduce the risk of CMV reactivation, which can be particularly concerning for individuals with weakened immune systems. Patients may wonder, 'What is Prevymis used for?' and the answer lies in its role as a prophylactic treatment against CMV, a common virus that can cause serious complications in immunocompromised individuals.

Side Effects

Common effects of Prevymis 240 mg may include gastrointestinal issues such as nausea, vomiting, and diarrhea. Some users might also experience fatigue or headache. These effects are generally mild and temporary, but it's important to monitor any persistent or severe symptoms.

Precautions & Warnings

Prevymis 240 mg should be handled with care, especially by individuals with known allergies to letermovir or any of its components. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should also be aware of potential interactions with other medications and inform their healthcare provider of all current treatments.

Avoid Interactions

Prevymis 240 mg may interact with certain medications, particularly those metabolized by the liver enzyme CYP3A. This includes drugs like cyclosporine, which is often used in transplant patients. Additionally, patients should avoid consuming grapefruit or grapefruit juice, as it can affect the metabolism of Prevymis and potentially increase the risk of side effects.

Frequently Asked Questions

Prevymis 240 mg is used to prevent cytomegalovirus (CMV) infection in adults who have received a stem cell transplant.

Prevymis is taken orally, typically as a film-coated tablet, and should be administered as directed by a healthcare professional.

Common side effects may include nausea, vomiting, diarrhea, fatigue, and headache.

Yes, Prevymis may interact with medications metabolized by the liver enzyme CYP3A, such as cyclosporine.

No, it is generally advised to avoid grapefruit and grapefruit juice while taking Prevymis, as it can affect the medication's metabolism.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.